Target intelligence / Profile preview

3-Ketoacyl CoA thiolase (KAT)

Target
KAT
Molecular classification
Enzyme, Thiolase
01

Overview

3-Ketoacyl-CoA thiolase (KAT, EC 2.3.1.16) is an enzyme that catalyzes the final step of the β-oxidation pathway, which is essential for fatty acid degradation in both prokaryotes and eukaryotes. This enzyme cleaves a two-carbon acetyl-CoA unit from 3-ketoacyl-CoA substrates, thereby shortening fatty acyl chains and enabling further rounds of β-oxidation or directing products to other metabolic pathways. Deficiency or dysfunction of specific KAT isoforms leads to metabolic disorders such as Medium Chain 3-Ketoacyl-CoA Thiolase Deficiency (MCKAT deficiency), characterized by impaired breakdown of certain fats resulting in toxic metabolite accumulation and energy production deficits. Engineered variants of KAT are being developed for synthetic biology applications.

Other names
Thiolase I
02

Mechanism of action

Catalyzes the thiolytic cleavage of 3-ketoacyl-CoAs to release acetyl-CoA and a shortened acyl-CoA.

03

Biological functions

Fatty acid degradationEnergy metabolismCarbon chain rearrangement
04

Disease associations

Fatty acid oxidation disordersMedium Chain 3-Ketoacyl-CoA Thiolase Deficiency (MCKAT deficiency)
05

Safety considerations

Substrate overload can lead to accumulation of upstream CoA esters, which may inhibit enzyme activity through product inhibition mechanisms.

Beyond the preview

Go deeper on 3-Ketoacyl CoA thiolase (KAT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-Ketoacyl CoA thiolase (KAT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call